Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-26T00:48:34.545Z Has data issue: false hasContentIssue false
  • English
  • Français

Activity of quinfamide against natural infections of Entamoeba criceti in hamsters: a new potent agent for intestinal amoebiasis

Published online by Cambridge University Press:  06 April 2009

R. G. Slighter ,
A. Yarinsky ,
H. P. Drobeck  and
D. M. Bailey
R. G. Slighter
Affiliation:
Departments of ParasitologySterling-Winthrop Research Institute, Rensselaer, NY 12144
A. Yarinsky
Affiliation:
Departments of ParasitologySterling-Winthrop Research Institute, Rensselaer, NY 12144
H. P. Drobeck
Affiliation:
ToxicologySterling-Winthrop Research Institute, Rensselaer, NY 12144
D. M. Bailey
Affiliation:
Medicinal ChemistrySterling-Winthrop Research Institute, Rensselaer, NY 12144
Get access Rights & Permissions [Opens in a new window]

Summary

A novel tetrahydroquinolinyl ester, quinfamide, administered orally in multiple doses for 3 days had an ED50, of 0·25 mg/kg/day (total dose 0·75 mg/kg) for eradicating Entamoeba criceti in hamsters in several tests. It was significantly more active by direct comparison than 3 commercially available amoebicides and at least as active as 2 other esters of the parent compound, 1-(dichloroacetyl)-1,2,3,4-tetrahydro-6-quinonnol. After administration of a single dose, ED50, calculations for quinfamide averaged 0·9 mg/kg. Quinfamide was considerably more active than the other tetrahydroquinolinols, diloxanide furoate and teclozan, and it was approximately 1·5 times more active than etofamide; a statistical significance between the latter 2 drugs could be demonstrated in one of 4 tests. Administered prophylactically, quinfamide was shown to protect hamsters from re-infection with E. criceti. It also inhibited propagation of E. histolytica in vitro at a concentration of 20 /tg/ml. No adverse effects were noted in rodents after a single dose as high as 10 g/kg. Daily administration to monkeys of doses up to 500 mg/kg for as long as 37 days produced no pharmacological aberrations during or after medication; haematological studies and urine analyses were normal and no gross or microscopical tissue changes attributable to quinfamide were observed. No toxicity was revealed following acute (2 g/kg) and chronic (500 mg/kg/day × 31 days) administration of the drug to dogs and rats, respectively.

Type
Research Article
Information
Parasitology , Volume 81 , Issue 1 , August 1980 , pp. 157 - 168
Copyright
Copyright © Cambridge University Press 1980

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Arcilla-latonio, A., Arcilla, C. A., & Diaz de Rivera, L. M., (1972). Clinical laboratory trials with teclozan (Falmonox) in mild cases of amebiasis. Journal of the Philippine Medical Association 48, 137–52.Google Scholar
Bailey, D. M., Mount, E. M., Siggins, J., Carlson, J. A., Yarinsky, A., & Slighter, R. G., (1979). 1-(Dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinol esters. New potent antiamebic agents. Journal of Medicinal Chemistry 22, 599–601.CrossRefGoogle ScholarPubMed
Berberian, D. A., Slighter, R. G., & Dennis, E. W., (1961) N, N′-bis(dichloroacetyl)-diamines as amebicidal agents. American Journal of Tropical Medicine and Hygiene 10, 503–9.CrossRefGoogle Scholar
Berberian, D. A., Slighter, R. G., & Surrey, A. R., (1961). in vitro and in vivo amebicidal activity of N, N′-bis(dichloroacetyl)diamines. Antibiotics and Chemotherapy 11, 245–55.Google Scholar
Bliss, C. I., (1952). VI. Assays where the variation in response is a function of the dose. In The Statistics of Bioassays, pp. 535–560. New York: Academic Press.Google Scholar
Dennis, E. W., & Berberian, D. A., (1954). Chemotherapeutic properties of Win 5047 (Mantomide). A new synthetic amebicide. Antibiotics and Chemotherapy 4, 554–60.Google Scholar
Dennis, E. W., Bebberian, D. A., & Hansen, S., (1949). Amebicidal activity of bismuthoxy-p-N-glycolylarsanilate and 7-iodo-4-(1-methyl-4-diethylamino-butylamino)quinoline. American Journal of Tropical Medicine 29, 683–9.Google Scholar
Fernandes, P., Sant'Anna, I. B., & Lima, D. C., (1974). Tratamento da amebiase intestinal em 24 horas com novo esquema posologico do teclosan. A Folha Medica 69, 296–8.Google Scholar
Miller, L. C., & Tainter, M. L., (1944). Estimation of the ED50 and its error by means of logarithmic-probit graph paper. Proceedings of the Society of Experimental Biology and Medicine 57, 261–4.CrossRefGoogle Scholar
Phillips, B. P., Diamond, L. S., Bartgis, I. L., & Stuppler, S. A., (1972). Results of intracecal inoculation of germ-free and conventional guinea pigs and germ-free rats with axenically cultivated Entamoeba histolytica. Journal of Protozoology 19, 495–9.CrossRefGoogle ScholarPubMed
Surrey, A. R., & Slighter, R. G., (1978). Teclozan:N, N′-bis(dichloroacetyl)-N, N′-bis(2-ethoxvethyl)-1,4-xylylenediamine. Drugs of Today 14, 454–60.Google Scholar